GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorio Reig Jofre SA (XMAD:RJF) » Definitions » ROE % Adjusted to Book Value

Laboratorio Reig Jofre (XMAD:RJF) ROE % Adjusted to Book Value : 3.47% (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Laboratorio Reig Jofre ROE % Adjusted to Book Value?

Laboratorio Reig Jofre's ROE % for the quarter that ended in Dec. 2023 was 3.02%. Laboratorio Reig Jofre's PB Ratio for the quarter that ended in Dec. 2023 was 0.87. Laboratorio Reig Jofre's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 3.47%.


Laboratorio Reig Jofre ROE % Adjusted to Book Value Historical Data

The historical data trend for Laboratorio Reig Jofre's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Reig Jofre ROE % Adjusted to Book Value Chart

Laboratorio Reig Jofre Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.81 1.73 2.05 4.86 5.43

Laboratorio Reig Jofre Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.52 9.11 - 4.64 3.47

Competitive Comparison of Laboratorio Reig Jofre's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Reig Jofre's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Laboratorio Reig Jofre's ROE % Adjusted to Book Value falls into.



Laboratorio Reig Jofre ROE % Adjusted to Book Value Calculation

Laboratorio Reig Jofre's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=4.72% / 0.87
=5.43%

Laboratorio Reig Jofre's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=3.02% / 0.87
=3.47%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratorio Reig Jofre ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Laboratorio Reig Jofre's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorio Reig Jofre (XMAD:RJF) Business Description

Traded in Other Exchanges
Address
Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.